Cel AI (CLAI) Competitors GBX 0.21 -0.04 (-16.00%) As of 03:42 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock CLAI vs. CBX, BYOT, ULVR, RKT, PZC, W7L, MCB, ACRL, SKIN, and REVBShould you be buying Cel AI stock or one of its competitors? The main competitors of Cel AI include Cellular Goods (CBX), Byotrol (BYOT), Unilever (ULVR), Reckitt Benckiser Group (RKT), PZ Cussons (PZC), Warpaint London (W7L), McBride (MCB), Accrol Group (ACRL), DeepVerge plc (SKIN.L) (SKIN), and Revolution Beauty Group (REVB). These companies are all part of the "household & personal products" industry. Cel AI vs. Cellular Goods Byotrol Unilever Reckitt Benckiser Group PZ Cussons Warpaint London McBride Accrol Group DeepVerge plc (SKIN.L) Revolution Beauty Group Cel AI (LON:CLAI) and Cellular Goods (LON:CBX) are both small-cap consumer defensive companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations, risk and media sentiment. Does the media prefer CLAI or CBX? In the previous week, Cel AI's average media sentiment score of 0.00 equaled Cellular Goods'average media sentiment score. Company Overall Sentiment Cel AI Neutral Cellular Goods Neutral Is CLAI or CBX more profitable? Cellular Goods has a net margin of 0.00% compared to Cel AI's net margin of -3,892.32%. Cellular Goods' return on equity of -93.04% beat Cel AI's return on equity.Company Net Margins Return on Equity Return on Assets Cel AI-3,892.32% -193.35% -50.24% Cellular Goods N/A -93.04%-54.98% Which has preferable earnings and valuation, CLAI or CBX? Cel AI has higher revenue and earnings than Cellular Goods. Cel AI is trading at a lower price-to-earnings ratio than Cellular Goods, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCel AI£57.18K20.86-£2.23M-£0.42-0.51Cellular Goods£13.06K0.00-£3.31M-£0.01N/A Which has more volatility & risk, CLAI or CBX? Cel AI has a beta of -1.6, suggesting that its stock price is 260% less volatile than the S&P 500. Comparatively, Cellular Goods has a beta of -1.39, suggesting that its stock price is 239% less volatile than the S&P 500. Does the MarketBeat Community believe in CLAI or CBX? Cel AI and Cellular Goods both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformCel AIN/AN/ACellular GoodsN/AN/A SummaryCel AI and Cellular Goods tied by winning 4 of the 8 factors compared between the two stocks. Get Cel AI News Delivered to You Automatically Sign up to receive the latest news and ratings for CLAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLAI vs. The Competition Export to ExcelMetricCel AIHousehold & Personal Products IndustryDefensive SectorLON ExchangeMarket Cap£1.19M£15.85B£6.87B£2.59BDividend YieldN/A2.45%3.16%4.97%P/E Ratio-0.5117.1311.66133.72Price / Sales20.86344.1784.59232,158.79Price / CashN/A17.16146.2628.12Price / Book2.202.942.874.58Net Income-£2.23M£912.33M£1.01B£5.84B7 Day Performance-20.75%1.73%0.39%2.88%1 Month Performance23.53%1.88%1.48%10.09%1 Year PerformanceN/A93.41%45.63%115.85% Cel AI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLAICel AIN/AGBX 0.21-16.0%N/AN/A£1.19M£57,175.59-0.515Gap DownCBXCellular GoodsN/AN/AN/AN/A£2.26M£13,058.00-37.505Gap UpBYOTByotrolN/AN/AN/AN/A£454,000.00£4.38M-22.0036Gap UpHigh Trading VolumeULVRUnilever0.8897 of 5 starsGBX 4,791-0.5%GBX 4,686.67-2.2%+14.2%£141.48B£70.72B21.67148,000RKTReckitt Benckiser Group0.3893 of 5 starsGBX 4,680+0.3%GBX 4,788.50+2.3%+8.3%£31.93B£13.78B21.4226,000PZCPZ Cussons2.4894 of 5 starsGBX 74.40+3.3%GBX 120+61.3%-23.1%£313.57M£530.68M-5.512,644W7LWarpaint London3.3397 of 5 starsGBX 380+5.6%GBX 680+78.9%-18.9%£301.18M£101.21M16.85141Earnings ReportAnalyst ForecastNews CoverageMCBMcBrideN/AGBX 140.40+5.7%N/A+36.2%£240.67M£930.83M7.17240ACRLAccrol GroupN/AN/AN/AN/A£124.36M£221.16M-3,900.00456SKINDeepVerge plc (SKIN.L)N/AN/AN/AN/A£31.79M£1.48M-12.731,030High Trading VolumeREVBRevolution Beauty GroupN/AGBX 8.70-1.5%N/A-70.6%£27.82M£173.87M-50.7110Positive NewsGap Up Related Companies and Tools Related Companies CBX Alternatives BYOT Alternatives ULVR Alternatives RKT Alternatives PZC Alternatives W7L Alternatives MCB Alternatives ACRL Alternatives SKIN Alternatives REVB Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CLAI) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cel AI PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Cel AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.